rs1836796

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_181351.5(NCAM1):​c.127+185T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.642 in 152,068 control chromosomes in the GnomAD database, including 33,710 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.64 ( 33710 hom., cov: 33)

Consequence

NCAM1
NM_181351.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.608

Publications

9 publications found
Variant links:
Genes affected
NCAM1 (HGNC:7656): (neural cell adhesion molecule 1) This gene encodes a cell adhesion protein which is a member of the immunoglobulin superfamily. The encoded protein is involved in cell-to-cell interactions as well as cell-matrix interactions during development and differentiation. The encoded protein plays a role in the development of the nervous system by regulating neurogenesis, neurite outgrowth, and cell migration. This protein is also involved in the expansion of T lymphocytes, B lymphocytes and natural killer (NK) cells which play an important role in immune surveillance. This protein plays a role in signal transduction by interacting with fibroblast growth factor receptors, N-cadherin and other components of the extracellular matrix and by triggering signalling cascades involving FYN-focal adhesion kinase (FAK), mitogen-activated protein kinase (MAPK), and phosphatidylinositol 3-kinase (PI3K). One prominent isoform of this gene, cell surface molecule CD56, plays a role in several myeloproliferative disorders such as acute myeloid leukemia and differential expression of this gene is associated with differential disease progression. For example, increased expression of CD56 is correlated with lower survival in acute myeloid leukemia patients whereas increased severity of COVID-19 is correlated with decreased abundance of CD56-expressing NK cells in peripheral blood. Alternative splicing results in multiple transcript variants encoding distinct protein isoforms. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.898 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NCAM1NM_181351.5 linkc.127+185T>G intron_variant Intron 2 of 19 ENST00000316851.12 NP_851996.2 P13591-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NCAM1ENST00000316851.12 linkc.127+185T>G intron_variant Intron 2 of 19 5 NM_181351.5 ENSP00000318472.8 P13591-2

Frequencies

GnomAD3 genomes
AF:
0.642
AC:
97547
AN:
151950
Hom.:
33652
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.906
Gnomad AMI
AF:
0.455
Gnomad AMR
AF:
0.607
Gnomad ASJ
AF:
0.542
Gnomad EAS
AF:
0.731
Gnomad SAS
AF:
0.580
Gnomad FIN
AF:
0.394
Gnomad MID
AF:
0.608
Gnomad NFE
AF:
0.534
Gnomad OTH
AF:
0.612
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.642
AC:
97660
AN:
152068
Hom.:
33710
Cov.:
33
AF XY:
0.634
AC XY:
47126
AN XY:
74296
show subpopulations
African (AFR)
AF:
0.906
AC:
37609
AN:
41516
American (AMR)
AF:
0.607
AC:
9279
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.542
AC:
1879
AN:
3468
East Asian (EAS)
AF:
0.731
AC:
3767
AN:
5156
South Asian (SAS)
AF:
0.578
AC:
2782
AN:
4810
European-Finnish (FIN)
AF:
0.394
AC:
4151
AN:
10542
Middle Eastern (MID)
AF:
0.602
AC:
177
AN:
294
European-Non Finnish (NFE)
AF:
0.534
AC:
36301
AN:
67978
Other (OTH)
AF:
0.617
AC:
1303
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1612
3224
4835
6447
8059
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
774
1548
2322
3096
3870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.559
Hom.:
19652
Bravo
AF:
0.671
Asia WGS
AF:
0.675
AC:
2348
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
1.3
DANN
Benign
0.55
PhyloP100
-0.61
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1836796; hg19: chr11-113073360; API